206 related articles for article (PubMed ID: 16339464)
1. Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia.
Honda F; Imai H; Ishikawa M; Kubota C; Shimizu T; Fukunaga M; Saito N
Stroke; 2006 Jan; 37(1):223-8. PubMed ID: 16339464
[TBL] [Abstract][Full Text] [Related]
2. An oral administration of cilostazol before focal ischemia reduces the infarct volume with delayed cerebral blood flow increase in rats.
Yuzawa I; Yamada M; Fujii K
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):281-6. PubMed ID: 18755408
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia.
Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S
Brain Res; 2015 Mar; 1602():53-61. PubMed ID: 25617822
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and -2.
Wakida K; Morimoto N; Shimazawa M; Hozumi I; Nagase H; Inuzuka T; Hara H
Brain Res; 2006 Oct; 1116(1):187-93. PubMed ID: 16952340
[TBL] [Abstract][Full Text] [Related]
5. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia.
Imai H; Masayasu H; Dewar D; Graham DI; Macrae IM
Stroke; 2001 Sep; 32(9):2149-54. PubMed ID: 11546910
[TBL] [Abstract][Full Text] [Related]
6. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage.
Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI study.
Lee JH; Lee YK; Ishikawa M; Koga K; Fukunaga M; Miyakoda G; Mori T; Hosokawa T; Hong KW
Brain Res; 2003 Dec; 994(1):91-8. PubMed ID: 14642452
[TBL] [Abstract][Full Text] [Related]
8. Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats.
Ito H; Hashimoto A; Matsumoto Y; Yao H; Miyakoda G
J Cereb Blood Flow Metab; 2010 Feb; 30(2):343-51. PubMed ID: 19809463
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats.
Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161
[TBL] [Abstract][Full Text] [Related]
10. Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia.
Lee EJ; Lee MY; Chen HY; Hsu YS; Wu TS; Chen ST; Chang GL
J Pineal Res; 2005 Jan; 38(1):42-52. PubMed ID: 15617536
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion.
Watanabe T; Zhang N; Liu M; Tanaka R; Mizuno Y; Urabe T
Stroke; 2006 Jun; 37(6):1539-45. PubMed ID: 16645134
[TBL] [Abstract][Full Text] [Related]
12. Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.
Tatlisumak T; Takano K; Carano RA; Fisher M
Stroke; 1996 Dec; 27(12):2292-7; discussion 2298. PubMed ID: 8969796
[TBL] [Abstract][Full Text] [Related]
13. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
14. Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
Park SY; Lee JH; Kim CD; Rhim BY; Hong KW; Lee WS
Brain Res; 2007 Jul; 1157():112-20. PubMed ID: 17521620
[TBL] [Abstract][Full Text] [Related]
15. The effect of cilostazol and aspirin pre-treatment against subsequent transient focal cerebral ischemia in rat.
Toda Y; Katsura K; Saito M; Inaba T; Sakurazawa M; Katayama Y
Neurol Res; 2014 Nov; 36(11):1011-9. PubMed ID: 24836463
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates ischemic brain injury and enhances neurogenesis in the subventricular zone of adult mice after transient focal cerebral ischemia.
Tanaka Y; Tanaka R; Liu M; Hattori N; Urabe T
Neuroscience; 2010 Dec; 171(4):1367-76. PubMed ID: 20933581
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia.
Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M
Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318
[TBL] [Abstract][Full Text] [Related]
18. Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat.
Woitzik J; Weinzierl N; Schilling L
Neurol Res; 2005 Jul; 27(5):509-15. PubMed ID: 15978177
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia.
Zhang F; White JG; Iadecola C
J Cereb Blood Flow Metab; 1994 Mar; 14(2):217-26. PubMed ID: 8113318
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
